Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccolò Bolli

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Blood|February 19, 2011
cpsf1 is required for definitive HSC survival in zebrafishNiccolò Bolli, Elspeth M Payne, Jennifer Rhodes, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
International Journal of Molecular Sciences|December 23, 2022
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple MyelomaAntonio Matera, Alessio Marella, Akihiro Maeda, et al.
Blood|June 10, 2011
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AMLElspeth M Payne, Niccolò Bolli, Jennifer Rhodes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation SequencingMattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Blood|February 19, 2011
cpsf1 is required for definitive HSC survival in zebrafishNiccolò Bolli, Elspeth M Payne, Jennifer Rhodes, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
International Journal of Molecular Sciences|December 23, 2022
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple MyelomaAntonio Matera, Alessio Marella, Akihiro Maeda, et al.
Blood|June 10, 2011
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AMLElspeth M Payne, Niccolò Bolli, Jennifer Rhodes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation SequencingMattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, et al.
Pageof 9